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New Biodegradable Polymer-Derived Precision Nanomedicine for
Targeted Drug Delivery and Treatment of Prostate Cancer
Paul Worsley, James Beach, Truptiben Patel and Santimukul Santra*
www.nanotheranosticlab.com

Department of Chemistry and KPRC, Pittsburg State University, Pittsburg, KS 66762. Phone: 620-235-4861; Email: ssantra@pittstate.edu

Introduction and Synthesis of the Polymer and Nanoformulation

Characterization of Polymer, Drug Encapsulation, and Folate Conjugation

ABSTRACT
Aliphatic polyester polymers are suitable for
delivering
cancer
therapeutics
for
targeted
treatment. Herein, we synthesized a linear,
biodegradable polyester polymer using polyethylene
glycol-300, sorbitol, glutaric acid and 4-pentynoic
acid as monomers. The synthesis was carried out
using standard melt polymerization technique and
catalyzed by Novozyme-435, an enzyme that is
more environmentally friendly than traditional
organic catalysts. Therapeutic agents and optical
imaging dyes were encapsulated by the polymer
during
the
formulation
of
water-dispersible
nanoparticles via solvent diffusion method. The
surface functional alkyne groups were used to
conjugate folic acid using “click” chemistry for
targeted delivery to tumors over-expressing folate
receptors. The efficacy of this nanomedicine delivery
system was gauged by targeting prostate cancer
cells. The results were analyzed by cytotoxicity
(MTT)
assays,
drug
release
studies,
and
fluorescence microscopy and the results will be
summarized in this presentation.

INTRODUCTION

Figure 2: FT-IR
spectroscopy
data showing a
weak O-H peak
at 3400 cm-1,
and strong
peaks at 2900
cm-1, 1700 cm-1,
1100 cm-1,
which indicate
the presence of
C-H, C=O, and
C-O bonds,
respectively.
Therefore,
polymerization
successfully
incorporated the
monomers.

Figure 1: Proton nuclear magnetic resonance spectroscopy showing
peaks that are consistent with successful incorporation of reactants.
Polymerization is confirmed by broad peaks.

Scheme 1: From left to right the molecules on top are sorbitol, glutaric acid, polyethylene
glycol, and 4-pentynoic acid. Note the composition of the starting materials consisting of
carbon, oxygen, and hydrogen, which is important for biodegradability as shown later.
Novozyme-435 acts as the catalyst in this synthesis.

By synthesizing a polymer from readily available,
biocompatible monomers the polymer was
ensured to be digestible in the body. The
incorporation of oxygen atoms also gives the
polymer amphiphilic properties.

Figure 3: Gel permeation chromatography showing only the
polymer, no oligomers nor monomers were present. The
polymer’s weight average molecular weight is 71,000 Daltons,
with a polydispersity index of 1.8.

This polymer utilizes an enzyme, Novozyme-435,
that accomplishes the same polymerization
without the need for many harsh chemicals. The
resulting polymer therefore maintains its
functionality while being more environmentally
friendly.
By modifying our polymer into a nanoparticle, we
were able to create a drug delivery system for
the treatment of prostate cancer.
The polymer was created with a few goals:
•
•
•
•
•

environmentally friendly
easy, one-step synthesis
diverse functionality with amphiphilic cavities
biocompatible and have a high molecular weight
able to encapsulate theranostic molecules

Scheme 2: This scheme describes the encapsulation of Taxol and Dil dye and then the
attachment of folate for prostate cancer treatment.

Figure 4: Thermogravimetric analysis shows degradation peak at
400 °C which suggests the polymer is biodegradable in the body.

Results and Discussion

Figure 5: This figure shows various characterizations of the polymeric nanoparticle
(PNP) A) Size distribution measured the PNP’s diameter to be 79.64 nanometers which
is acceptable for receptor mediated endocytosis. B) Zeta potential measured the charge
across the surface of the PNP to be -19.7 mV, indicating successful attachment of folate
to the surface of the nanoparticle. C) Absorbance was tested to confirm the presence of
folate and determine if the Dil dye had successfully been encapsulated. D) Fluorescence
More obviously confirmed the presence of Dil dye in the PNP, once again showing
successful encapsulation.

Conclusions
As shown by this poster presentation, we created a
nanoparticle that was able to meet the goals:
•
•
•
•

target prostate cancer
biodegradable, biocompatible, high MW polymer
simple, environmentally friendly synthesis
amphiphilic cavities to encapsulate chemicals

In this poster we extensively covered one potential
use of our nanoparticle - prostate cancer therapy.
But the nanoparticle we created is better described REFERENCES
§ Shaw et al., Biomaterials Sci. 2020, 8, 1481-1772.
as a drug delivery system.
Our nanoparticle may be useful in:
Figure 6: This diagram shows the method by which the nanoparticle
enters and terminates the prostate cancer cell. Folate allows the
nanoparticle to enter the cell, where Taxol is released, and apoptosis
follows.

Figure 7: LNCaP cells (left) overexpress folate receptors and thus take in the
nanoparticle loaded with Taxol. PC3 cells (right) do not overexpress receptors
and therefore do not readily accept the nanoparticle. Within 24 hours of
treatment with PNP-Dil-Fol-Taxol less than 20% of LNCaP cells survived.

Figure 8: MTT assay showing LNCaP cells treated
with PNP-Dil (top row), PNP-Dil-Fol (middle row), and
PNP-Dil-Fol-Taxol (bottom row). Only PNP-Dil-Fol-Taxol
treatment led to cell death.

•
•
•
•

transporting other imaging dyes
delivering hydrophobic chemicals to cells
preventing chemotherapy effects (ex. hair loss)
reducing the chemotherapeutic drug dosage
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